https://www.selleckchem.com/pr....oducts/trastuzumab-d
- To investigate the incidence of, factors associated with, and differences between synchronous and metachronous colorectal peritoneal metastases (CPM) in a population-based cohort. - Data from the Netherlands Cancer Registry were used. All patients diagnosed with colorectal cancer (CRC) between 1 January and June 30, 2015 were evaluated for synchronous or metachronous CPM (diagnosis ≤90 or 90 days after surgery for primary CRC), and survival in 2019 (median follow-up 38.4 months). - Of 7233 included patients, 409 (5.
Like
Comment
Share
